glutathione and covid fatigue Long-COVID post-viral chronic affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study The challenges in symptomatic therapy

634 AAK1 inhibitor LX-9211: Junctional protein 2-associated kinase 1 (AAK1) is widely expressed in the brain and spinal cord and is a viable target for the treatment of neuropathic pain, and BMS-986176/LX-9211 is a novel class of bis(iso)aryl ethers that are highly selective, CNS-permeable, and potent AAK1 inhibitors

SARS-CoV-2 specific CD8 + T cells in the nasal mucosa were found to persist 2 months after viral clearance, indicating the long-term effects of COVID-19 on immune reactions in the upper respiratory tract (Roukens et al., 2022)

This can help to naturally supplement deficiencies and improve your symptoms

A SIRVA diagnosis should not prevent receiving future vaccines.